Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta®

Clinical trial NCT01735175 · COMPLETED

Trial details

NCT number: NCT01735175
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neutropenic Complications Breast Neoplasms Chemotherapy-induced Neutropenia Chemotherapeutic Toxicity

Start date: 2012-06-01
Primary completion: 2013-05-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.